Early Amiodarone in Shockable Cardiac Arrest
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 585 participants.
Also called NCT06680869
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 585 participants
- Registry
-
NCT06680869
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06680869. Randomized; no masking; primary purpose treatment. Start 2025-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Amiodarone in Shockable Cardiac Arrest
- Acronym
- Early-Amio
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Amiodarone Hydrochloride Injection
- Intervention (Other)
- Usual Care Protocol
- Lead sponsor
- Oregon Health and Science University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct06680869- Content hash
0d6eb12a3e091f6e4ad727648aa14c6af392c9cdb8c8e446059bc1b687a0f27f